We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $236M
1-Year Est. Return 51.76%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+51.76%
3 Year Est. Return
+106.38%
5 Year Est. Return
+132.3%
10 Year Est. Return
+407.64%
AUM
$512M
AUM Growth
+$19.9M
Cap. Flow
-$12.8M
Cap. Flow %
-2.51%
Top 10 Hldgs %
34.55%
Holding
137
New
12
Increased
33
Reduced
43
Closed
8

Sector Composition

Rank Sector Weight
1 Energy 25.75%
2 Industrials 20.16%
3 Healthcare 10.09%
4 Communication Services 9.51%
5 Consumer Staples 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
126
DELISTED
Celgene Corp
CELG
-9,600
Closed -$670K

Similar funds

Chelsea Counsel Company's Q2 2014 Portfolio in Review

As of Q2 2014, Chelsea Counsel Company held 137 positions worth $512M, up 4% from $492M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chelsea Counsel Company's Q2 2014 filing shows 12 new, 33 increased, 43 reduced and 8 closed positions. Its largest new stake was Biogen: 1,623 shares worth $512K. The largest sale was Unilever NV New York Registry Shares, an estimated $7.75M.

By sector, the portfolio is most concentrated in Energy at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Chelsea Counsel Company's largest Q2 2014 buy was Biogen: 1,623 shares worth $512K.
  • Chelsea Counsel Company added most to Plains All American Pipeline in Q2 2014, an estimated $1.65M increase.
  • Chelsea Counsel Company's biggest Q2 2014 reduction was Unilever NV New York Registry Shares, cutting an estimated $7.75M.
  • Chelsea Counsel Company fully exited Celgene Corp in Q2 2014, selling an estimated $670K.
  • Chelsea Counsel Company's ten largest holdings make up 35% of its $512M portfolio in Q2 2014.
  • Chelsea Counsel Company opened 12 new positions and closed 8 in Q2 2014.
  • Chelsea Counsel Company's portfolio value rose 4% quarter-over-quarter to $512M.

Based on Chelsea Counsel Company's 13F filing for Q2 2014, filed 4 Sep 2014.